S. 366 · 116th Congress
FLAT Prices Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DurbinSponsor6 cosponsors · 6 D
4 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
What it does: CRS summary · Introduced in Senate · Feb 6, 2019
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: FLAT Prices Act
Also known as: Forcing Limits on Abusive and Tumultuous Prices
Latest action (Feb 6, 2019): Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Policy area: Health · Origin: Senate · Introduced: Feb 6, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.